BioSupply Trends Quarterly logo
Search
Close this search box.
Fall 2022 - Innovation

HHS Launches the Inaugural PandemicX 2022 Cohort

The U.S. Department of Health and Human Services has launched the inaugural PandemicX 2022 cohort, a novel program to accelerate private-public collaboration comprised of 15 health technology startups. The PandemicX startups were selected through a rigorous process, 66 percent of which are both female-founded and minority-owned. The startup’s proposed solutions align with federal health challenges and address health equity barriers and other disparities exacerbated by COVID-19 using data and innovation.

Through the six-month program, the startups had access to curriculum, mentorship, resources and other collaborations to scale their businesses and work toward creating actionable solutions to federal challenges, including health equity by design, national public health solutions, behavioral and mental health, socioeconomic outcome indicators and community resilience.

“The world needs technological and business innovation to increase equitable assets and to create a resilient society,” said Micky Tripathi, U.S. National Coordinator for Health IT. “We know HealthTech startups are a force of good to help make wellness, health and wealth an accessible right, not a privilege. You cannot have health without resilience; you cannot have health without inclusion.”

A list of all the startups, including specific details, can be viewed at masschallenge.org/announcement/mcht22cohort.

References

Inaugural PandemicX Accelerator Graduates Cohort Creating a Model for Future Public-Private Collaboration. U.S. Department of Health and Human Services press release, Aug. 18, 2022. Accessed at www.hhs.gov/about/news/2022/08/18/inaugural-pandemicx-accelerator-graduates-cohort-creating-a-model-for-future-public-private-collaboration.html.

BSTQ Staff
BioSupply Trends Quarterly [BSTQ] is the definitive source for industry trends, news and information for the biopharmaceuticals marketplace. With timely and critical information, each themed issue covers topics ranging from product breakthroughs, industry insights and innovations, up-to-the-minute news on the latest clinical trials, accessibility, and service and safety concerns.